Exhibit 10.39
Certain identified information has been excluded from this exhibit (indicated by “[***]”) because it is both not material and is the type that the registrant treats as private or confidential.
Execution Version
AMENDMENT NO. 1 TO CREDIT, SECURITY AND GUARANTY AGREEMENT (REVOLVING LOAN)
This AMENDMENT NO. 1 TO CREDIT, SECURITY AND GUARANTY AGREEMENT (REVOLVING LOAN) (this “Agreement”) is made as of January 24, 2023, by and among KEYSTONE DENTAL, INC. (the “Borrower”), KEYSTONE DENTAL HOLDINGS, INC. (“Holdings”), IMPLANT SOLUTIONS PTY LTD., PALTOP ADVANCED DENTAL SOLUTIONS LTD., IOS INNOVATIONS PTY LTD (each individually as a “Guarantor”, and collectively, the “Guarantors”), MIDCAP FUNDING IV TRUST, a Delaware statutory trust, as Agent (in such capacity, together with its successors and assigns, “Agent”) and the other financial institutions or other entities from time to time parties to the Credit Agreement referenced below, each as a Lender.
RECITALS
A. Agent, Lenders, and the Credit Parties have entered into that certain Credit, Security and Guaranty Agreement (Revolving Loan), dated as of June 7, 2022 (the “Original Credit Agreement” and as amended hereby and as it may be further amended, modified, supplemented and restated from time to time, the “Credit Agreement”), pursuant to which the Lenders have agreed to make certain advances of money and to extend certain financial accommodations to Borrowers in the amounts and manner set forth in the Credit Agreement.
B. The Credit Parties have requested, and Agent and all Lenders have agreed, to amend certain provisions of the Original Credit Agreement to, among other things, amend the Floor, certain provisions regarding the Deferred Revolving Loan Origination Fee and certain provisions regarding the Lockbox Account, in accordance with the terms and subject to the conditions set forth herein.
AGREEMENT
NOW, THEREFORE, in consideration of the foregoing, the terms and conditions set forth in this Agreement, and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Agent, Lenders and the Credit Parties hereby agree as follows:
1. Recitals. This Agreement shall constitute a Financing Document and the Recitals and each reference to the Credit Agreement, unless otherwise expressly noted, will be deemed to reference the Credit Agreement as amended hereby. The Recitals set forth above shall be construed as part of this Agreement as if set forth fully in the body of this Agreement and capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Credit Agreement (including those capitalized terms used in the Recitals hereto).
2. Amendments to Original Credit Agreement. Subject to the terms and conditions of this Agreement, including, without limitation, the conditions to effectiveness set forth in Section 4 below, the Original Credit Agreement is hereby amended as follows:
(a) Section 1.1 of the Original Credit Agreement is hereby amended by adding the following definitions in alphabetical order therein:
“First Amendment” shall mean that certain Amendment No. 1 to Credit, Security and Guaranty Agreement (Revolving Loan), dated as of the First Amendment Effective Date, by and among the Credit Parties, Agent and the Lenders.
“First Amendment Effective Date” shall mean January 24, 2023.
MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)
“Lockbox Transition Period” has the meaning ascribed to such term in Section 2.11(b).
(b) Section 1.1 of the Original Credit Agreement is hereby amended by amending and restating the definitions of “Base Rate”, and “Floor”, respectively, as follows:
“Base Rate” means a per annum rate of interest equal to the greater of (a) two and one half percent (2.50%) per annum and (b) a per annum rate of interest equal to the rate of interest announced, from time to time, within Wells Fargo Bank, National Association (“Wells Fargo”) at its principal office in San Francisco as its “prime rate,” with the understanding that the “prime rate” is one of Wells Fargo’s base rates (not necessarily the lowest of such rates) and serves as the basis upon which effective rates of interest are calculated for those loans making reference thereto and is evidenced by the recording thereof after its announcement in such internal publications as Wells Fargo may designate; provided, however, that Agent may, upon prior written notice to Borrower, choose a reasonably comparable index or source to use as the basis for the Base Rate.
“Floor” means the rate per annum of interest equal to 2.50%.
(c) Section 2.2(g) of the Original Credit Agreement is hereby amended and restated as follows:
“(g) Deferred Revolving Loan Origination Fee. If Lenders’ funding obligations in respect of the Revolving Loan Commitment under this Agreement terminate or are permanently reduced for any reason (whether by voluntary termination by Borrowers, by reason of the occurrence of an Event of Default or the automatic termination of the Revolving Loan Commitments (including any automatic termination due to the occurrence of an Event of Default described in Section 10.1(f)) or otherwise) prior to the Maturity Date, Borrowers shall pay to Agent on the date of such reduction, for the benefit of all Lenders committed to make Revolving Loans on the Closing Date, a fee as compensation for the costs of such Lenders being prepared to make funds available to Borrowers under this Agreement, equal to an amount determined by multiplying the amount of the Revolving Loan Commitment so terminated or permanently reduced by the following applicable percentage amount: (x) three percent (3.00%) for the first year following the First Amendment Effective Date, (y) two percent (2.00%) for the second year following the First Amendment Effective Date, and (z) and one percent (1.00%) thereafter. All fees payable pursuant to this paragraph shall be deemed fully-earned on of the Closing Date and non-refundable once paid.”
(d) Section 2.11(a) of the Original Credit Agreement is hereby amended and restated as follows:
“(a) By the date that is five (5) Business Days prior to the initial borrowing of the Revolving Loans (or such later date as Agent may agree in writing) (the “Lockbox Activation Date”), a lockbox (the “Lockbox”) and a Lockbox Account with a United States depository institution reasonably acceptable to Agent (the “Lockbox Bank”), subject to the provisions of this Agreement, and shall execute with the Lockbox Bank a Deposit Account Control Agreement and such other agreements related to such Lockbox and/or Lockbox Account as Agent may require. At all times following the Lockbox Transition Period, Borrowers shall ensure that all collections of Accounts are paid directly from Account Debtors (i) into the Lockbox for deposit into the Lockbox Account and/or (ii) directly into the Lockbox Account; provided, however, that unless Agent shall otherwise direct by written notice to Borrowers, Borrowers shall be permitted to cause
2
MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)
Account Debtors who are individuals to pay Accounts directly to Borrowers, which Borrowers shall then administer and apply in the manner required below. All funds deposited into a Lockbox Account after the Lockbox Activation Date shall be transferred into the Payment Account (or, prior to the time of the initial borrowing of the Revolving Loans, such Deposit Account of Borrower as Agent may direct in its sole discretion) by the close of each Business Day. At all times during the Lockbox Transition Period, Borrower shall ensure that, by the close of business on Friday of each calendar week (commencing with the first full calendar week after the First Amendment Effective Date), all collections received by or on behalf of Borrowers in respect of Accounts prior to such Friday are transferred, pursuant to an irrevocable standing wire instruction, into a Lockbox Account that is subject to a Deposit Account Control Agreement.”
(e) Section 2.11(b) of the Original Credit Agreement is hereby amended and restated as follows:
“(b) By the date that is ninety (90) days after the Lockbox Activation Date (or such later date as Agent may agree in writing) (such period, the “Lockbox Transition Period”), Borrower shall ensure that all Account Debtors are instructed to pay, and all collections are paid, directly into the Lockbox for deposit into the Lockbox Account and/or directly into the Lockbox Account.”
(f) Article 4 of the Original Credit Agreement is hereby amended to add the following new Section 4.19 immediately following the end of Section 4.18 therein:
“Section 4.19 Board Observer Rights. Agent and/or its designees (including any Lender) shall have the right, on behalf of itself and/or the other Lenders, to: (a) receive notice of all meetings (both regular and special) of the board of directors (or other comparable body) and/or the equity holders of each Credit Party, and each committee of any such board of directors (or other comparable body) (such notice to be delivered or mailed to Agent as specified in this Agreement at the same time as notice is given to the members of any such board of directors (or other comparable body) and/or committee and/or equity holders) but in no event later than two (2) Business Days prior to the date of such meeting; (b) be entitled to attend all such meetings (telephonically or in person, at Agent’s or its designee’s discretion) in a nonvoting capacity; (c) receive all notices, information, reports and minutes of meetings, which are furnished (or made available) to the members of any such board of directors (or other comparable body) and/or committee and/or equity holders at the same time and in the same manner as the same is furnished (or made available) to such members, and (d) be entitled to participate in all discussions conducted at such meetings. If any action is proposed to be taken by any such board of directors (or other comparable body) and/or committee by written consent in lieu of a meeting, the applicable Credit Party shall provide written notice thereof to the Agent or its applicable designees, which notice shall describe in reasonable detail the nature and substance of such proposed action and shall be delivered not later than the date upon which any member of any such board of directors (or other comparable body) and/or committee receives the same. Each Credit Party shall provide the Agent or its applicable designees with a copy of each such written consent not later than five (5) Business Days after it has been signed by a sufficient number of signatories to make it effective. Agent or, as applicable, Agent’s designees shall not constitute a member of any such board of directors (or other comparable body) and/or committee and shall not be entitled to vote on any matters presented at meetings of any such board of directors (or other comparable body) and/or committee or to consent to any matter as to which the consent of any such board of directors (or other comparable body) and/or committee shall have been requested. Each Credit Party shall reimburse the Agent
3
MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)
and/or its designees, as applicable, for all reasonable out-of-pocket expenses incurred in connection with attending such meetings and/or exercising any rights under this Section 4.19. Notwithstanding the foregoing, Agent, and or its designee may be excluded from receiving any such information and materials (or the relevant portions thereof) or from attending such meetings (or the relevant portions thereof) pursuant to this Section 4.19 to avoid a conflict of interest, to protect attorney-client privilege or with respect to highly confidential information of third parties; provided that, for the avoidance of doubt, in all cases Credit Parties shall still be required to notify Agent of all meetings under clause (a) above regardless of whether Agent and/or its designees are excluded from such meeting or portion of such meeting and provide Agent (together with such notice) the criteria pursuant to which Agent and/or its designees are being excluded from such meeting.”
3. Representations and Warranties; Reaffirmation of Security Interest. Each Credit Party hereby confirms that all of the representations and warranties set forth in the Credit Agreement are true and correct in all material respects (without duplication of any materiality qualifier in the text of such representation or warranty) with respect to such Credit Party as of the date hereof except to the extent that any such representation or warranty relates to a specific date in which case such representation or warranty shall be true and correct as of such earlier date. Each Credit Party reaffirms its obligations under each Security Document, including each Australian Security Agreement and each Israeli Security Document, to which it is a party, and confirms and agrees that all security interests and Liens granted to the Agent continue in full force and effect, and all Collateral remains free and clear of any Liens, other than Permitted Liens. Nothing herein is intended to impair or limit the validity, priority or extent of Agent’s security interests in and Liens on the Collateral. Each Credit Party acknowledges and agrees that the Credit Agreement, the other Financing Documents and this Agreement constitute the legal, valid and binding obligation of such Credit Party, and are enforceable against such Credit Party in accordance with its terms, except as the enforceability thereof may be limited by bankruptcy, insolvency or other similar laws relating to the enforcement of creditors’ rights generally and by general equitable principles.
4. Conditions to Effectiveness. This Agreement shall become effective as of the date on which each of the following conditions have been satisfied, as determined by Agent in its reasonable discretion:
(a) Agent shall have received (including by way electronic transmission) a duly authorized, executed and delivered counterpart of the signature page to this Agreement from each Credit Party, Agent and the Lenders;
(b) Agent shall have received a duly executed copy of Amendment No. 1 to Credit, Security and Guaranty Agreement (Term Loan), dated as of the date hereof, in respect of the Affiliated Credit Agreement;
(c) Agent shall have received from the Credit Parties updated versions of Schedule 3.19, Schedule 5.14, Schedule 9.2(b) and Schedule 9.2(d), in form and substance reasonably satisfactory to Agent, in each case, correcting all outdated, inaccurate, incomplete or misleading information;
(d) Agent shall have received from the Credit Parties all of the fees due on the First Amendment Effective Date pursuant to the Credit Agreement;
(e) all representations and warranties of Credit Parties contained herein shall be true and correct in all material respects (without duplication of any materiality qualifier in the text of such representation or warranty) as of the date hereof except to the extent that any such representation or warranty relates to a specific date in which case such representation or warranty shall be true and correct as of such earlier date (and such parties’ delivery of their respective signatures hereto shall be deemed to be its certification thereof); and
4
MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)
(f) prior to and after giving effect to the agreements set forth herein, no Default or Event of Default shall exist under any of the Financing Documents.
5. Costs and Fees. Borrowers agree to promptly pay, or reimburse promptly following demand for, all reasonable and documented costs and expenses of Agent (including, without limitation, the reasonable and documented fees, costs and expenses of counsel to Agent) in connection with the preparation, negotiation, execution and delivery of this Agreement and any other Financing Documents or other agreements prepared, negotiated, executed or delivered in connection with this Agreement or transactions contemplated hereby, subject to and in accordance with Section 13.14 of the Credit Agreement.
6. Release. In consideration of the agreements of Agent and Lenders contained herein and for other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, Credit Party, voluntarily, knowingly, unconditionally and irrevocably, with specific and express intent, for and on behalf of itself and all of its respective parents, subsidiaries, affiliates, members, managers, predecessors, successors, and assigns, and each of their respective current and former directors, officers, shareholders, agents, and employees, and each of their respective predecessors, successors, heirs, and assigns (individually and collectively, the “Releasing Parties”) does hereby fully and completely release, acquit and forever discharge each of Agent, Lenders, and each their respective parents, subsidiaries, affiliates, members, managers, shareholders, directors, officers and employees, and each of their respective predecessors, successors, heirs, and assigns (individually and collectively, the “Released Parties”), of and from any and all actions, causes of action, suits, debts, disputes, damages, claims, obligations, liabilities, costs, expenses and demands of any kind whatsoever, at law or in equity, whether matured or unmatured, liquidated or unliquidated, vested or contingent, choate or inchoate, known or unknown that the Releasing Parties (or any of them) has against the Released Parties or any of them (whether directly or indirectly). Each Credit Party acknowledges that the foregoing release is a material inducement to Agent’s and each Lender’s decision to enter into this Agreement and agree to the modifications contemplated hereunder, and has been relied upon by Agent and Lenders in connection therewith.
7. No Waiver or Novation. The execution, delivery and effectiveness of this Agreement shall not, except as expressly provided in this Agreement, operate as a waiver of any right, power or remedy of Agent, nor constitute a waiver of any provision of the Credit Agreement, the Financing Documents or any other documents, instruments and agreements executed or delivered in connection with any of the foregoing. Nothing herein is intended or shall be construed as a waiver of any existing Defaults or Events of Default under the Credit Agreement or the other Financing Documents or any of Agent’s rights and remedies in respect of such Defaults or Events of Default. This Agreement (together with any other document executed in connection herewith) is not intended to be, nor shall it be construed as, a novation of the Credit Agreement.
8. Affirmation. Except as specifically amended pursuant to the terms hereof, each Credit Party hereby acknowledges and agrees that the Credit Agreement and all other Financing Documents (and all covenants, terms, conditions and agreements therein) shall remain in full force and effect, and are hereby ratified and confirmed in all respects by such Credit Party. Each Credit Party covenants and agrees to comply with all of the terms, covenants and conditions of the Credit Agreement and the Financing Documents, notwithstanding any prior course of conduct, waivers, releases or other actions or inactions on Agent’s or any Lender’s part which might otherwise constitute or be construed as a waiver of or amendment to such terms, covenants and conditions.
5
MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)
9. Miscellaneous.
(a) Reference to the Effect on the Credit Agreement. Upon the effectiveness of this Agreement, each reference in the Credit Agreement to “this Agreement,” “hereunder,” “hereof,” “herein,” or words of similar import shall mean and be a reference to the Credit Agreement, as amended by this Agreement. Except as specifically amended above, the Credit Agreement, and all other Financing Documents (and all covenants, terms, conditions and agreements therein), shall remain in full force and effect, and are hereby ratified and confirmed in all respects by each Credit Party.
(b) Governing Law. THIS AGREEMENT AND ALL DISPUTES AND OTHER MATTERS RELATING HERETO OR ARISING THEREFROM (WHETHER SOUNDING IN CONTRACT LAW, TORT LAW OR OTHERWISE), SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICTS OF LAWS PRINCIPLES (OTHER THAN SECTION 5-1401 OF THE GENERAL OBLIGATIONS LAW).
(c) Incorporation of Credit Agreement Provisions. The provisions contained in Section 11.6 (Indemnification), Section 13.8(b) (Submission to Jurisdiction) and Section 13.9 (Waiver of Jury Trial) of the Credit Agreement are incorporated herein by reference to the same extent as if reproduced herein in their entirety.
(d) Headings. Section headings in this Agreement are included for convenience of reference only and shall not constitute a part of this Agreement for any other purpose.
(e) Counterparts. This Agreement may be signed in any number of counterparts, each of which shall be deemed an original and all of which when taken together shall constitute one and the same instrument. Signatures by facsimile or by electronic mail delivery of an electronic version of any executed signature page shall bind the parties hereto.
(f) Entire Agreement. This Agreement constitutes the entire agreement and understanding among the parties hereto and supersedes any and all prior agreements and understandings, oral or written, relating to the subject matter hereof.
(g) Severability. In case any provision of or obligation under this Agreement shall be invalid, illegal or unenforceable in any applicable jurisdiction, the validity, legality and enforceability of the remaining provisions or obligations, or of such provision or obligation in any other jurisdiction, shall not in any way be affected or impaired thereby.
(h) Successors/Assigns. This Agreement shall bind, and the rights hereunder shall inure to, the respective successors and assigns of the parties hereto, subject to the provisions of the Credit Agreement and the other Financing Documents.
[SIGNATURES APPEAR ON FOLLOWING PAGES]
6
MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)
IN WITNESS WHEREOF, intending to be legally bound, and intending that this document constitute an agreement executed under seal, the undersigned have executed this Agreement under seal as of the day and year first hereinabove set forth.
AGENT: | MIDCAP FUNDING IV TRUST, | |||||
as Agent | ||||||
By: | Apollo Capital Management, L.P., | |||||
its investment manager | ||||||
By: | Apollo Capital Management GP, LLC, | |||||
its general partner | ||||||
By: | ||||||
Name: Maurice Amsellem | ||||||
Title: Authorized Signatory |
[Signatures Continue on Following Page]
MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)
LENDERS: | MIDCAP FUNDING IV TRUST | |||||||
By: | Apollo Capital Management, L.P., | |||||||
its investment manager | ||||||||
By: | Apollo Capital Management GP, LLC, | |||||||
its general partner | ||||||||
By: | ||||||||
Name: Maurice Amsellem | ||||||||
Title: Authorized Signatory |
[Signatures Continue on Following Page]
MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)
BORROWERS: | KEYSTONE DENTAL, INC. | |||||
By: | ||||||
Name: | Amnon Tamir | |||||
Title: | CFO |
GUARANTORS: | KEYSTONE DENTAL HOLDINGS, INC. | |||||
By: | ||||||
Name: | Amnon Tamir | |||||
Title: | CFO |
PALTOP ADVANCED DENTAL SOLUTIONS, LTD. | ||||||
By: | ||||||
Name: | Erez Cohen | |||||
Title: | General Manager |
MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)
Executed by IMPLANT SOLUTIONS PTY LTD
ACN 126 288 864 in accordance with section 127 of the
Corporations Act 2001 (Cth):
Signature of Director | Signature of Director/Secretary |
Amnon Tamir | Michael Tuckman | |||||||
Name of Director | Name of Director/Secretary |
Executed by IOS INNOVATIONS PTY LTD ACN
640 856 873 in accordance with section 127 of the
Corporations Act 2001 (Cth):
Signature of Director | Signature of Director/Secretary |
Amnon Tamir | Michael Tuckman | |||||||
Name of Director | Name of Director/Secretary |
MidCap / Keystone / Amendment No. 1 to Credit Agreement (Revolving Loan)
INTELLECTUAL PROPERTY (REGISTRATIONS AND APPLICATIONS) | ||||||||||||||||
Credit Party that is Owner of | Name / Identifier of IP | Type of IP (e.g., patent, TM, ©, mask work) | Matterid | Patent Number | Filing Date | Expiration Date | Country | Status | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002001 | 7,249,949 | 2004-06-29 | 2004-06-29 | UNITED STATES | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002AT1 | 1763324 | 2005-06-23 | 2005-06-23 | AUSTRIA | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002AU1 | 2005267241 | 2005-06-23 | 2005-06-23 | AUSTRALIA | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002BE1 | 1763324 | 2005-06-23 | 2005-06-23 | BELGIUM | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002CA1 | 2562696 | 2005-06-23 | 2005-06-23 | CANADA | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002CH1 | 1763324 | 2005-06-23 | 2005-06-23 | SWITZERLAND | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002CN1 | ZL200580016480.X | 2005-06-23 | 2005-06-23 | CHINA | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002CN2 | 102512254 B | 2005-06-23 | 2005-06-23 | CHINA | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002CO1 | 1374 | 2005-06-23 | COLOMBIA | ISSUED | |||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002CZ1 | 1763324 | 2005-06-23 | 2005-06-23 | CZECH REPUBLIC | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002DE1 | 1763324 | 2005-06-23 | 2005-06-23 | GERMANY | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002DK1 | 1763324 | 2005-06-23 | 2005-06-23 | DENMARK | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002EP1 | 1763324 | �� | 2005-06-23 | 2005-06-23 | EUROPEAN PATENT CONVENTION | ISSUED | |||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002ES1 | 1763324 | 2005-06-23 | 2005-06-23 | SPAIN | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002FI1 | 1763324 | 2005-06-23 | 2005-06-23 | FINLAND | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002FR1 | 1763324 | 2005-06-23 | 2005-06-23 | FRANCE | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002GB1 | 1763324 | 2005-06-23 | 2005-06-23 | UNITED KINGDOM | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002GR1 | 3071244.B2 | 2005-06-23 | GREECE | ISSUED | |||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002HK1 | HK1104447 | 2005-06-23 | 2007-09-04 | HONG KONG | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002HU1 | 1763324 | 2005-06-23 | 2005-06-23 | HUNGARY | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002IE1 | 1763324 | 2005-06-23 | 2005-06-23 | IRELAND | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002IL1 | 178624 | 2005-06-23 | 2005-06-23 | ISRAEL | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002IT1 | 832021000098732 | 2005-06-23 | 2005-06-23 | ITALY | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002JP1 | 4886683 | 2005-06-23 | 2005-06-23 | JAPAN | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002KR1 | 10-1168454 | 2005-06-23 | 2005-06-23 | SOUTH KOREA | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002LU1 | 1763324 | 2005-06-23 | 2005-06-23 | LUXEMBOURG | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962- 0002MC1 | 1763324 | 2005-06-23 | 2005-06-23 | MONACO | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962- 0002MX1 | 255986 | 2005-06-23 | 2005-06-23 | MEXICO | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002NL1 | 1763324 | 2005-06-23 | 2005-06-23 | NETHERLANDS | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002PL1 | 1763324 | 2005-06-23 | 2005-06-23 | POLAND | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002PT1 | 1763324 | 2005-06-23 | 2005-06-23 | PORTUGAL | ISSUED | ||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002SG1 | 126168 | 2005-06-23 | 2005-06-23 | SINGAPORE | ISSUED | ||||||||
Keystone Dental, Inc. | CARRY AND DRIVE DEVICE AND METHOD FOR DENTAL IMPLANT AND/OR COMPONENTS THEREOF | Patent | 29962-0005002 | 8,029,282 | 2007-09-14 | 2005-08-10 | UNITED STATES | ISSUED | ||||||||
Keystone Dental, Inc. | CARRY AND DRIVE DEVICE AND METHOD FOR DENTAL IMPLANT AND/OR COMPONENTS THEREOF | Patent | 29962-0005CA1 | 2615812 | 2006-07-31 | 2006-07-31 | CANADA | ISSUED | ||||||||
Keystone Dental, Inc. | CARRY AND DRIVE DEVICE AND METHOD FOR DENTAL IMPLANT AND/OR COMPONENTS THEREOF | Patent | 29962-0005IL1 | 189412 | 2006-07-31 | 2008-02-10 | ISRAEL | ISSUED | ||||||||
Keystone Dental, Inc. | CARRY AND DRIVE DEVICE AND METHOD FOR DENTAL IMPLANT AND/OR COMPONENTS THEREOF | Patent | 29962-0005JP1 | 5094722 | 2006-07-31 | 2006-07-31 | JAPAN | ISSUED | ||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0018001 | D612,055 | 2007-04-23 | UNITED STATES | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0018EU1 | 000594601-0001 | 2006-09-25 | EUROPEAN UNION | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0018EU2 | 000594601-0002 | 2006-09-25 | EUROPEAN UNION | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0018EU3 | 000594601-0003 | 2006-09-25 | EUROPEAN UNION | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0018GB1 | 90005946010001 | 2006-09-25 | UNITED KINGDOM | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0018GB2 | 90005946010002 | 2006-09-25 | UNITED KINGDOM | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0018GB3 | 90005946010003 | 2006-09-25 | UNITED KINGDOM | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0018IT1 | 0000090314 | 2005-09-26 | ITALY | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0019EU1 | 000631601-0001 | 2006-12-01 | EUROPEAN UNION | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0019EU2 | 000631601-0002 | 2006-12-01 | EUROPEAN UNION | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0019GB1 | 90006316010001 | 2006-12-01 | UNITED KINGDOM | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0019GB2 | 90006316010002 | 2006-12-01 | UNITED KINGDOM | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0020EU1 | 000642145-0001 | 2006-12-21 | EUROPEAN UNION | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0020EU2 | 000642145-0002 | 2006-12-21 | EUROPEAN UNION | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0020GB1 | 90006421450001 | 2006-12-21 | UNITED KINGDOM | ISSUED | |||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0020GB2 | 90006421450002 | 2006-12-21 | UNITED KINGDOM | ISSUED | |||||||||
Keystone Dental, Inc. | OSTEOINTEGRATIVE INTERFACE FOR IMPLANTABLE PROSTHESES AND A METHOD FOR THE TREATMENTOF THE OSTEOINTEGRATIVE INTERFACE | Patent | 29962-0024DE1 | 60301796.7 | 2003-05-30 | 2003-05-30 | GERMANY | ISSUED | ||||||||
Keystone Dental, Inc. | IMPRESSION CAP | Patent | 29962-0027001 | 7,163,398 | 2002-03-13 | 2022-03-13 | UNITED STATES | EXPIRED | ||||||||
Keystone Dental, Inc. | IMPLANT-DRIVER ASSEMBLY | Patent | 29962-0028001 | 7,887,325 | 2008-04-04 | 2008-04-04 | UNITED STATES | ISSUED | ||||||||
Keystone Dental, Inc. | urface Treatment For Metals, Particularly For Titanium, Alloys, Containing Titanium, Alloys Containing Titanium Oxides, For Medical, Surgical And Implantological Use | Patent | 29962-0031EP1 | 2180083 | 2008-10-21 | EUROPE | ISSUED | |||||||||
Keystone Dental, Inc. | SURFACE TREATMENT FOR TITANIUM, ALLOYS, CONTAINING TITANIUM, ALLOYS CONTAINING TITATNIUM OXIDES, FOR MEDICAL, SURGICAL AND IMPLANTOLOGICAL USE | Patent | 29962-0031DE1 | 602008015841.1 | 2008-10-21 | GERMANY | ISSUED | |||||||||
Keystone Dental, Inc. | SURFACE TREATMENT FOR TITANIUM, ALLOYS, CONTAINING TITANIUM, ALLOYS CONTAINING TITATNIUM OXIDES, FOR MEDICAL, SURGICAL AND IMPLANTOLOGICAL USE | Patent | 29962-0031FR1 | 2180083 | 2008-10-21 | 2008-10-21 | FRANCE | ISSUED | ||||||||
Keystone Dental, Inc. | SURFACE TREATMENT FOR TITANIUM, ALLOYS, CONTAINING TITANIUM, ALLOYS CONTAINING TITATNIUM OXIDES, FOR MEDICAL, SURGICAL AND IMPLANTOLOGICAL USE | Patent | 29962-0031GB1 | 2180083 | 2008-10-21 | 2008-10-21 | UNITED KINGDOM | ISSUED | ||||||||
Keystone Dental, Inc. | SURFACE TREATMENT FOR TITANIUM, ALLOYS, CONTAINING TITANIUM, ALLOYS CONTAINING TITATNIUM OXIDES, FOR MEDICAL, SURGICAL AND IMPLANTOLOGICAL USE | Patent | 29962-0031IT1 | 2180083 | 2008-10-21 | 2008-10-21 | ITALY | ISSUED | ||||||||
Keystone Dental, Inc. | DENTAL IMPLANT | Patent | 29962-0033001 | D612,055 | 2007-04-23 | UNITED STATES | ISSUED | |||||||||
Keystone Dental, Inc. | INTERNAL CONNECTION DENTAL IMPLANT | Patent | 29962-0002BR1 | PI0509047-4 | 2005-06-23 | BRAZIL | ISSUED | |||||||||
Implant Solutions Pty Ltd | Nexus Plus invention - A dental prosthesis | Patent | M53056082 (29962- 0094AU2) | 2019101679 | 2019-11-07 | 2027-11-07 | Australia (Innovation Patent) | Granted | ||||||||
Implant Solutions Pty Ltd | Scan gauge invention - Apparatus for facilitating acquisition of a scan and an intraoral scanning procedure | Patent | M53095602 (29962- 0091AU1) | 2020102538 (Innovation Patent) | 2020-09-30 | 2028-09-30 | Australia | Granted | ||||||||
Implant Solutions Pty Ltd | Scan gauge invention - Design Protection - Intraoral scan body | Patent | M53097500 (29962- 0096AU1) | 202015430 | 2020-10-02 | 2030-10-02 | Australia | Granted | ||||||||
Implant Solutions Pty Ltd | Scan gauge invention - Design Protection - Dental instruments | Patent | M53122213 (29962- 0096EU1) | 008484836-0001 | 2021-04-01 | 2026-04-01 | European Community (EUIPO) | Granted | ||||||||
Implant Solutions Pty Ltd | Scan gauge invention - Design Protection - Intraoral scan body | Patent | M53122226 (29962- 0096HK1) | 2117803.7 | 2021-04-01 | 2046-04-01 | Hong Kong | Granted | ||||||||
Implant Solutions Pty Ltd | Scan gauge invention - Design Protection - Intraoral scan body | Patent | M53122252 (29962- 0096GB1) | 6127816 | 2021-04-01 | 2046-03-31 | United Kingdom | Granted | ||||||||
Implant Solutions Pty Ltd | Nexus Plus invention - A dental prosthesis | Patent | M53053547 (29962- 0094TW1) | 108140464 | 2019-11-07 | No estimate provided by Derwent or PatSnap | Taiwan | Pending | ||||||||
Implant Solutions Pty Ltd | Nexus Plus invention - A dental prosthesis | Patent | M53119132 (29962- 0094AU1) | 2019317632 | 2019-11-07 | No estimate provided by Derwent or PatSnap | Australia | Pending | ||||||||
Implant Solutions Pty Ltd | Nexus Plus invention - A dental prosthesis | Patent | M53119145 (29962- 0094EP1) | 19848244 | 2019-11-07 | No estimate provided by Derwent or PatSnap | European Patent Convention | Pending | ||||||||
Implant Solutions Pty Ltd | Nexus Plus invention - A dental prosthesis | Patent | M53119158 (29962- 0094JP1) | 2021-520310 | 2019-11-07 | PatSnap provides no estimated expiration date for AU2018904243 | Japan | Pending | ||||||||
Implant Solutions Pty Ltd | Nexus Plus invention - A dental prosthesis | Patent | M53119171 (29962- 0094NZ1) | 774413 | 2019-11-07 | PatSnap provides no estimated expiration date for AU2018904243 | New Zealand | Pending | ||||||||
Implant Solutions Pty Ltd | Nexus Plus invention - A dental prosthesis | Patent | M53119184 (29962- 0094US1) | 17/286706 | 2019-11-07 | No estimate provided by Derwent or PatSnap | United States of America | Pending | ||||||||
Implant Solutions Pty Ltd | Dental Jig invention - Denture preparation assembly, method and apparatus | Patent | M53140283 (29962- 0095AU1) | 2020232981 | 2020-03-06 | No estimate provided by Derwent or PatSnap | Australia | Pending | ||||||||
Implant Solutions Pty Ltd | Dental Jig invention - Denture preparation assembly, method and apparatus | Patent | M53140296 (29962- 0095EP1) | 20766705.6 | 2020-03-06 | EP3934565 (not yet published – European Patent Register link) | Europe | Pending | ||||||||
Implant Solutions Pty Ltd | Dental Jig invention - Denture preparation assembly, method and apparatus | Patent | M53140309 (29962- 0095JP1) | 2021-547840 | 2020-03-06 | Not listed in the JPO’s site yet | Japan | Pending | ||||||||
Implant Solutions Pty Ltd | Dental Jig invention - Denture preparation assembly, method and apparatus | Patent | M53140322 (29962- 0095NZ1) | 779047 | 2020-03-06 | NZ779047 (National Phase entry of PCT – link here) | New Zealand | Pending | ||||||||
Implant Solutions Pty Ltd | Dental Jig invention - Denture preparation assembly, method and apparatus | Patent | M53140335 (29962- 0095US1) | 17/433457 | 2020-03-06 | Unable to locate in Derwent, PatSnap or USPTO Public Pair | United States of America | Pending | ||||||||
Implant Solutions Pty Ltd | Scan gauge invention - Apparatus for facilitating acquisition of a scan and an intraoral scanning procedure | Patent | M53101010 (29962- 0091TW) | 109138152 | 2020-11-03 | PatSnap provides no estimated expiration date for AU 2019904154 | Taiwan | Pending | ||||||||
Implant Solutions Pty Ltd | Scan gauge invention - Design Protection - Intraoral scan body | Patent | M53122239 (20443- 0096001) | 29/776891 | 2021-04-01 | Design Patent Application Number – not available in public PAIR yet | United States of America | Pending | ||||||||
Implant Solutions Pty Ltd | Scan gauge invention - Design Protection - Intraoral scan body | Patent | M53122265 (20443- 0096JP1) | 2021-006954 | 2021-04-01 | 2046-04-01 | Japan | Pending | ||||||||
Paltop Advanced Dental Solutions Ltd | Dental Implant | Patent | 15/440,462 | 8731310,987,201 | 2017-02-23 | United States of America | Issued | |||||||||
Paltop Advanced Dental Solutions Ltd | Implant Placement Key | Patent | 15/906,081 | 8972510,792,132 | 2018-02-27 | United States of America | Issued | |||||||||
Paltop Advanced Dental Solutions Ltd | Drilling Guide | Patent | 16/020,332 | 9003810,987,196 | 2018-06-27 | United States of America | Issued | |||||||||
Keystone Dental, Inc. | KEY-PLAN | Trademark | 2087999 | 2021-03-26 | CA | Pending | ||||||||||
Keystone Dental, Inc. | KEY-PLAN | Trademark | 18415847 | 2021-03-03 | 2031-03-03 | EU | Registered | |||||||||
Keystone Dental, Inc. | GENESIS | Trademark | 35478532 | 2018-12-21 | CN | Abandoned | ||||||||||
Keystone Dental, Inc. | MOLARIS | Trademark | 90/655735 | 2021-04-19 | 2028-02-02 | US | Registered | |||||||||
Keystone Dental, Inc. | I-HEXMRT | Trademark | 1957785 | 2019-04-17 | CA | Pending | ||||||||||
Keystone Dental, Inc. | GENESIS | Trademark | 17917568 | 2018-06-14 | 2028-06-14 | EU | Registered | |||||||||
Keystone Dental, Inc. | GENESIS | Trademark | 32077040 | 2018-07-05 | CN | Abandoned | ||||||||||
Keystone Dental, Inc. | GENESIS | Trademark | 3697685 | 2021-09-20 | 2031-09-20 | GB | Registered | |||||||||
Keystone Dental, Inc. | DYNACORE | Trademark | 1929267 | 2018-11-07 | 2031-11-23 | CA | Registered | |||||||||
Keystone Dental, Inc. | TI-LOBE TITE | Trademark | 88/698026 | 2019-11-19 | 26-07-2027 | US | Registered | |||||||||
Keystone Dental, Inc. | K-LEAN | Trademark | 88/712316 | 2019-12-02 | US | Pending | ||||||||||
Keystone Dental, Inc. | WE FOLLOW SCIENCE | Trademark | 88/712318 | 2019-12-02 | US | Pending | ||||||||||
Keystone Dental, Inc. | DIVA | Trademark | 2001172 | 2019-12-13 | CA | Pending | ||||||||||
Keystone Dental, Inc. | DIVA | Trademark | 88/725261 | 2019-12-12 | US | Pending | ||||||||||
Keystone Dental, Inc. | GENESIS THE BIOMIMETIC IMPLANT SYSTEM | Trademark | 77/949640 | 2010-03-03 | 2032-01-31 | US | Registered | |||||||||
Keystone Dental, Inc. | BIOSPARK | Trademark | 9222929 | 2011-03-17 | 2022-04-14 | CN | Abandoned | |||||||||
Keystone Dental, Inc. | STAGE-1 | Trademark | 2814127 | 2002-08-14 | 2022-08-14 | EU | Abandoned | |||||||||
Keystone Dental, Inc. | STAGE-1 | Trademark | 50107/2002 | 2002-08-15 | 2022-08-15 | CH | Abandoned | |||||||||
Keystone Dental, Inc. | ANATITE | Trademark | 40-2011-0012891 | 2011-03-14 | 2022-08-24 | KR | Abandoned | |||||||||
Keystone Dental, Inc. | BIOSPARK | Trademark | 40-2011-0013195 | 2011-03-15 | 2022-08-24 | KR | Abandoned | |||||||||
Keystone Dental, Inc. | CALFORMA | Trademark | 1250328 | 2005-03-11 | 2022-10-18 | CA | Abandoned | |||||||||
Keystone Dental, Inc. | SMARTER THINKING. SIMPLER DESIGN | Trademark | 85/444120 | 2011-10-11 | 2023-01-08 | US | Registered | |||||||||
Keystone Dental, Inc. | STAGE-1 | Trademark | 585335 | 2003-01-27 | 2023-01-27 | MX | Registered | |||||||||
Keystone Dental, Inc. | TILOBEMAXX | Trademark | 86/924908 | 2016-03-01 | 2023-05-21 | US | Registered | |||||||||
Keystone Dental, Inc. | PRIMASOLO | Trademark | 1259438 | 2005-05-31 | 2023-10-24 | CA | Registered | |||||||||
Keystone Dental, Inc. | PRIMACONNEX | Trademark | 1259439 | 2005-05-31 | 2023-11-04 | CA | Registered | |||||||||
Keystone Dental, Inc. | PALTOP | Trademark | 87/570958 | 2017-08-16 | 2023-11-13 | US | Registered | |||||||||
Keystone Dental, Inc. | GENESIS THE BIOMIMETIC IMPLANT SYSTEM & DESIGN | Trademark | 85/154709 | 2010-10-18 | 2023-11-19 | US | Registered | |||||||||
Keystone Dental, Inc. | KEYSTONE | Trademark | 87/361863 | 2017-03-07 | 2023-05-29 | US | Registered | |||||||||
Keystone Dental, Inc. | PRIMA PLUS | Trademark | 87/863775 | 2018-04-04 | 2024-02-21 | US | Registered | |||||||||
Keystone Dental, Inc. | GENESIS | Trademark | 87/761042 | 2018-01-18 | 2023-02-21 | US | Registered | |||||||||
Keystone Dental, Inc. | RESTORE | Trademark | 197563 | 1994-04-28 | 2024-04-28 | MX | Registered | |||||||||
Keystone Dental, Inc. | PRIMA | Trademark | 87/446220 | 2017-05-11 | 2024-04-30 | US | Registered | |||||||||
Keystone Dental, Inc. | RESTORE | Trademark | RM1994C002159 | 1994-05-16 | 2024-05-16 | IT | Registered | |||||||||
Keystone Dental, Inc. | BIOSPARK | Trademark | 85/131895 | 2010-09-17 | 2024-05-27 | US | Registered | |||||||||
Keystone Dental, Inc. | ANATITE | Trademark | 85/131880 | 2010-09-17 | 2024-05-27 | US | Registered | |||||||||
Keystone Dental, Inc. | SUPERCAT | Trademark | 3364792 | 2002-11-11 | 2024-08-21 | CN | Registered | |||||||||
Keystone Dental, Inc. | RESTORE | Trademark | 74/471499 | 1993-12-16 | 2024-12-27 | US | Registered | |||||||||
Keystone Dental, Inc. | DYNACORE | Trademark | 88/190786 | 2018-11-12 | 2025-04-08 | US | Registered | |||||||||
Keystone Dental, Inc. | PRIMASOLO | Trademark | 4466521 | 2005-06-01 | 2025-06-01 | EU | Registered | |||||||||
Keystone Dental, Inc. | PRIMACONNEX | Trademark | 4466538 | 2005-06-01 | 2025-06-01 | EU | Registered | |||||||||
Keystone Dental, Inc. | TILOBE | Trademark | 1336453 | 2007-02-22 | 2025-06-21 | CA | Registered | |||||||||
Keystone Dental, Inc. | RESTORE | Trademark | 40-1994-0021402 | 1994-05-30 | 2026-01-16 | KR | Registered | |||||||||
Keystone Dental, Inc. | I-HEXMRT | Trademark | 88/387869 | 2019-04-16 | 2026-06-08 | US | Registered | |||||||||
Keystone Dental, Inc. | PRIMACONNEX | Trademark | 78/531583 | 2004-12-13 | 2026-09-05 | US | Registered | |||||||||
Keystone Dental, Inc. | PRIMASOLO | Trademark | 78/531560 | 2004-12-13 | 2026-09-05 | US | Registered | |||||||||
Keystone Dental, Inc. | TILOBE | Trademark | 5704002 | 2007-02-21 | 2027-02-21 | EU | Registered | |||||||||
Keystone Dental, Inc. | TILOBE | Trademark | 838429 | 2007-02-23 | 2027-02-23 | MX | Registered | |||||||||
Keystone Dental, Inc. | RESTORE | Trademark | 274576 | 1994-05-18 | 2027-06-23 | CL | Registered | |||||||||
Keystone Dental, Inc. | TILOBE | Trademark | 2007-015603 | 2007-02-23 | 2027-07-06 | JP | Registered | |||||||||
Keystone Dental, Inc. | TILOBE | Trademark | 96008889 | 2007-02-27 | 2027-11-30 | TW | Registered | |||||||||
Keystone Dental, Inc. | TILOBE | Trademark | 40-2007-0010379 | 2007-02-23 | 2027-12-17 | KR | Registered | |||||||||
Keystone Dental, Inc. | GENESIS | Trademark | 74150/2018 | 2018-06-04 | 2028-06-04 | CH | Registered | |||||||||
Keystone Dental, Inc. | TILOBE | Trademark | 764039 | 2007-02-26 | 2028-07-10 | CL | Registered | |||||||||
Keystone Dental, Inc. | TILOBE | Trademark | 78/964909 | 2006-08-31 | 2028-12-09 | US | Registered | |||||||||
Keystone Dental, Inc. | DYNAMATRIX | Trademark | 77/470114 | 2008-05-09 | 2029-09-08 | US | Registered | |||||||||
Keystone Dental, Inc. | GENESIS | Trademark | 884703 | 1998-07-16 | 2029-10-28 | CA | Registered | |||||||||
Keystone Dental, Inc. | GENESIS | Trademark | 2019/117377 | 2019-11-25 | 2029-11-25 | TR | Registered | |||||||||
Keystone Dental, Inc. | Genesis The Biomimetic Implant System & design | Trademark | 9045097 | 2010-04-21 | 2030-04-21 | EU | Registered | |||||||||
Keystone Dental, Inc. | GENESIS THE BIOMIMETIC IMPLANT SYSTEM | Trademark | 1983943 | 2019-09-06 | 2030-09-23 | CA | Registered | |||||||||
Keystone Dental, Inc. | GENESIS | Trademark | 1900450 | 2018-05-23 | 2030-12-15 | CA | Registered | |||||||||
Keystone Dental, Inc. | PALTOP | Trademark | 236203 | 2011-03-03 | 2031-03-03 | IL | Registered | |||||||||
Keystone Dental, Inc. | ANATITE | Trademark | 9802562 | 2011-03-11 | 2031-03-10 | GB | Registered | |||||||||
Keystone Dental, Inc. | ANATITE | Trademark | 9802562 | 2011-03-11 | 2031-03-11 | EU | Registered | |||||||||
Keystone Dental, Inc. | BIOSPARK | Trademark | 9808247 | 2011-03-14 | 2031-03-13 | GB | Registered | |||||||||
Keystone Dental, Inc. | BIOSPARK | Trademark | 9808247 | 2011-03-14 | 2031-03-14 | EU | Registered | |||||||||
Keystone Dental, Inc. | TILOBEMAXX | Trademark | 1788789 | 2016-06-27 | 2032-11-10 | CA | Registered | |||||||||
Keystone Dental, Inc. | BIOSPARK | Trademark | 909808247 | 2011-03-14 | 2031-03-14 | GB | Registered | |||||||||
Keystone Dental, Inc. | GENESIS THE BIOMIMETIC IMPLANT SYSTEM | Trademark | 909045097 | 2010-04-21 | 2030-04-21 | GB | Registered | |||||||||
Keystone Dental, Inc. | PRIMACONNEX | Trademark | 904466538 | 2005-06-01 | 2025-06-01 | GB | Registered | |||||||||
Keystone Dental, Inc. | PRIMASOLO | Trademark | 904466521 | 2005-06-01 | 2025-06-01 | GB | Registered |
Keystone Dental, Inc. | STAGE-1 | Trademark | 902814127 | 2002-08-14 | GB | Abandoned | ||||||||||
Keystone Dental, Inc. | TILOBE | Trademark | 905704002 | 2007-02-21 | 2027-02-21 | GB | Registered | |||||||||
Keystone Dental, Inc. | QUICK-CAP | Trademark | 76425572 | 2002-06-25 | US | Registered | ||||||||||
Keystone Dental, Inc. | RESTORE | Trademark | 902255686 | 2014-04-23 | 2024-04-23 | IT | Registered | |||||||||
Keystone Dental, Inc. | DYNAFIBER | Trademark | 2022-02-07 | CA | Pending | |||||||||||
Keystone Dental, Inc. | GENESIS ACTIVE | Trademark | 2022-11-22 | US | Pending | |||||||||||
Keystone Dental, Inc. | DYNAFIBER | Trademark | 97252730 | 2022-02-03 | U.S. | Pending | ||||||||||
Implant Solutions Pty Ltd | Biaxial | ORG (Trademark) | 1933584 | 2018-06-13 | 2018-06-13 | Australia | Registered | |||||||||
Implant Solutions Pty Ltd | Just in Time | ORG (Trademark) | 2130594 | 2020-10-30 | 2020-10-30 | Australia | Registered | |||||||||
Implant Solutions Pty Ltd | NEXUS | ORG (Trademark) | 2251183 | 2022-03-02 | Australia | Pending | ||||||||||
Implant Solutions Pty Ltd | Nexus iOS | DIV (Trademark) | 2182200 | 2020-10-08 | 2020-10-08 | Australia | Registered | |||||||||
Implant Solutions Pty Ltd | Nexus iOS | ORG (Trademark) | 2126993 | 2020-10-08 | Australia | Accepted | ||||||||||
Implant Solutions Pty Ltd | Nexus iOS (Logo) | Trademark | Australia | Pending | ||||||||||||
Implant Solutions Pty Ltd | Nexus iOS (Logo) | Trademark | Australia | Pending | ||||||||||||
Implant Solutions Pty Ltd | Nexus iOS (Logo) | Trademark | Australia | Pending | ||||||||||||
Implant Solutions Pty Ltd | Nexus Suprastructures | ORG (Trademark) | 2126998 | 2020-10-08 | Australia | Accepted | ||||||||||
Implant Solutions Pty Ltd | Nexus Suprastructures | DIV (Trademark) | 2182197 | 2020-10-08 | 2020-10-08 | Australia | Registered | |||||||||
Implant Solutions Pty Ltd | Osteon Medical Logo | ORG (Trademark) | 1933583 | 2018-06-13 | 2018-06-13 | Australia | Registered | |||||||||
Implant Solutions Pty Ltd | Overlapping Triangle Logo | ORG (Trademark) | 2275290 | 2022-06-15 | Australia | Accepted | ||||||||||
Implant Solutions Pty Ltd | Biaxial | PROT (Trademark) | 1598224 | 2021-05-27 | 2021-05-27 | China | Registered | |||||||||
Implant Solutions Pty Ltd | Just in Time | Trademark | China | Pending | ||||||||||||
Implant Solutions Pty Ltd | Just in Time | Trademark | China | Pending | ||||||||||||
Implant Solutions Pty Ltd | Osteon Medical Logo | Trademark | China | Pending | ||||||||||||
Implant Solutions Pty Ltd | Osteon Medical Logo | Trademark | China | Pending | ||||||||||||
Implant Solutions Pty Ltd | Osteon Medical Logo | Trademark | China | Pending | ||||||||||||
Implant Solutions Pty Ltd | Biaxial | PROT (Trademark) | 1598224 | 2021-05-27 | 2021-05-27 | European Union | Registered | |||||||||
Implant Solutions Pty Ltd | Just in Time | PROT (Trademark) | 1597936 | 2021-05-27 | 2021-05-27 | European Union | Registered | |||||||||
Implant Solutions Pty Ltd | NEXUS | PROT (Trademark) | 1684234 | 2022-08-17 | European Union | Accepted | ||||||||||
Implant Solutions Pty Ltd | Nexus iOS | PROT (Trademark) | 1603615 | 2021-06-30 | 2021-06-30 | European Union | Registered | |||||||||
Implant Solutions Pty Ltd | Nexus Suprastructures | PROT (Trademark) | 1603679 | 2021-06-30 | 2021-06-30 | European Union | Registered | |||||||||
Implant Solutions Pty Ltd | Osteon Medical Logo | PROT (Trademark) | 1599778 | 2021-05-27 | 2021-05-27 | European Union | Registered | |||||||||
Implant Solutions Pty Ltd | Overlapping Triangle logo | PROT (Trademark) | 1678016 | 2022-07-05 | European Union | Accepted | ||||||||||
Implant Solutions Pty Ltd | Biaxial | ORG (Trademark) | 1598224 | 2021-05-27 | 2021-05-27 | International Bureau (WIPO) | Registered | |||||||||
Implant Solutions Pty Ltd | Just in Time | ORG (Trademark) | 1597936 | 2021-05-27 | 2021-05-27 | International Bureau (WIPO) | Registered | |||||||||
Implant Solutions Pty Ltd | NEXUS | ORG (Trademark) | 1684234 | 2022-08-17 | 2022-03-02 | International Bureau (WIPO) | Registered | |||||||||
Implant Solutions Pty Ltd | Nexus iOS | ORG (Trademark) | 1603615 | 2021-06-30 | 2021-06-30 | International Bureau (WIPO) | Registered | |||||||||
Implant Solutions Pty Ltd | Nexus Suprastructures | ORG (Trademark) | 1603679 | 2021-06-30 | 2021-06-30 | International Bureau (WIPO) | Registered | |||||||||
Implant Solutions Pty Ltd | Osteon Medical Logo | ORG (Trademark) | 1599778 | 2021-05-27 | 2021-05-27 | International Bureau (WIPO) | Registered | |||||||||
Implant Solutions Pty Ltd | Overlapping Triangle Logo | ORG (Trademark) | 1678699 | 2022-07-20 | International Bureau (WIPO) | Pending | ||||||||||
Implant Solutions Pty Ltd | Overlapping Triangle logo | ORG (Trademark) | 1678016 | 2022-07-05 | 2022-07-05 | International Bureau (WIPO) | Registered | |||||||||
Implant Solutions Pty Ltd | Biaxial | PROT (Trademark) | 1182226 | 2021-05-27 | 2021-05-27 | New Zealand | Registered | |||||||||
Implant Solutions Pty Ltd | Just in Time | PROT (Trademark) | 1182148 | 2021-05-27 | 2021-05-27 | New Zealand | Registered | |||||||||
Implant Solutions Pty Ltd | NEXUS | PROT (Trademark) | 1220044 | 2022-08-17 | New Zealand | Pending | ||||||||||
Implant Solutions Pty Ltd | Nexus iOS | PROT (Trademark) | 1184858 | 2021-06-30 | 2021-06-30 | New Zealand | Registered | |||||||||
Implant Solutions Pty Ltd | Nexus Suprastructures | PROT (Trademark) | 1184779 | 2021-06-30 | 2021-06-30 | New Zealand | Registered | |||||||||
Implant Solutions Pty Ltd | Osteon Medical Logo | PROT (Trademark) | 1182890 | 2021-05-27 | 2021-05-27 | New Zealand | Registered | |||||||||
Implant Solutions Pty Ltd | Overlapping Triangle logo | PROT (Trademark) | 1217381 | 2022-07-05 | New Zealand | Pending | ||||||||||
Implant Solutions Pty Ltd | Biaxial | PROT (Trademark) | 1598224 | 2021-05-27 | 2021-11-11 | United Kingdom | Registered | |||||||||
Implant Solutions Pty Ltd | Just in Time | PROT (Trademark) | WO0000001597936 | 2021-05-27 | 2021-05-27 | United Kingdom | Registered | |||||||||
Implant Solutions Pty Ltd | NEXUS | PROT (Trademark) | 1684234 | 2022-08-17 | United Kingdom | Pending | ||||||||||
Implant Solutions Pty Ltd | Nexus iOS | PROT (Trademark) | 1603615 | 2021-06-30 | 2021-06-30 | United Kingdom | Registered | |||||||||
Implant Solutions Pty Ltd | Nexus Suprastructures | PROT (Trademark) | 1603679 | 2021-06-30 | 2021-06-30 | United Kingdom | Registered | |||||||||
Implant Solutions Pty Ltd | Osteon Medical Logo | PROT (Trademark) | 1599778 | 2021-05-27 | 2021-05-27 | United Kingdom | Registered | |||||||||
Implant Solutions Pty Ltd | Overlapping Triangle logo | PROT (Trademark) | 1678016 | 2022-07-05 | 2022-07-05 | United Kingdom | Registered | |||||||||
Implant Solutions Pty Ltd | Biaxial | PROT (Trademark) | 79313879 | 2021-05-27 | United States of America | Accepted | ||||||||||
Implant Solutions Pty Ltd | Just in Time | PROT (Trademark) | 79313779 | 2021-05-27 | 2021-05-27 | United States of America | Registered | |||||||||
Implant Solutions Pty Ltd | NEXUS | PROT (Trademark) | 79350164 | 2022-08-17 | United States of America | Pending | ||||||||||
Implant Solutions Pty Ltd | Nexus iOS | PROT (Trademark) | 79316234 | 2021-06-30 | 2021-06-30 | United States of America | Registered | |||||||||
Implant Solutions Pty Ltd | Nexus iOS | PROT (Trademark) | 90736553 | 2021-05-26 | United States of America | Allowed | ||||||||||
Implant Solutions Pty Ltd | Nexus Suprastructures | PROT (Trademark) | 79316255 | 2021-06-30 | 2021-06-30 | United States of America | Registered | |||||||||
Implant Solutions Pty Ltd | NEXUS SUPRASTRUCTURES | PROT (Trademark) | 90736537 | 2021-05-26 | United States of America | Allowed | ||||||||||
Implant Solutions Pty Ltd | Osteon Medical Logo | PROT (Trademark) | 79314551 | 2021-05-27 | United States of America | Accepted | ||||||||||
Implant Solutions Pty Ltd | Overlapping Triangle logo | PROT (Trademark) | 79347498 | 2022-07-05 | United States of America | Pending | ||||||||||
Implant Solutions Pty Ltd | NEXUS IOS INNOVATIVE IOS TECHNOLOGIES | Trademark | 2126996 | Australia | Pending |
Schedule 5.14 — Deposit Accounts and Securities Accounts
[***]
Schedule 9.2(b) – Collateral Information
Filing Offices
Keystone Dental Holdings, Inc. | - Secretary of State of the State of Delaware | |||
Keystone Dental, Inc. | - Secretary of State of the State of Delaware | |||
US IP Collateral | - United States Patent and Trademark Office |
Registered Office and Principal Place of Business of Each Loan Party and its Subsidiaries
Keystone Dental Holdings, Inc.
154 Middlesex Turnpike
Burlington, MA 01803
Keystone Dental Inc.
154 Middlesex Turnpike
Burlington, MA 01803
Southern Implants, Inc. (dormant)
154 Middlesex Turnpike
Burlington, MA 01803
SBT Dental LLC (dormant)
154 Middlesex Turnpike
Burlington, MA 01803
Paltop USA, Inc
154 Middlesex Turnpike
Burlington, MA 01803
Paltop Advanced Dental Solutions, Ltd.
Hashita 5 Caesarea
Caesarea Israel
Implant Solutions Pty Ltd (trading as Osteon Medical)
759-767 Springvale Road, Mulgrave, Victoria, 3170,
Australia
IOS Innovations Pty Ltd
759-767 Springvale Road, Mulgrave, Victoria, 3170,
Australia
Osteon Digital Japan [Co., Ltd].
3-5-4 Nagayoshi Kawanabe, Hirano-ku, Osaka-shi,
Osaka, Japan
Osteon Medical Europe SAS
11 Rue Des Aulnes – 69410 Champagne Au Mont
D’Or, France
Locations of Collateral and Books and Records
Leased business location operated by Credit Parties
154 Middlesex Turnpike
Burlington, MA 01803
Leased business location operated by Credit Parties
13645 Alton Parkway, Unit A
Irvine, CA 92618
Leased business location operated by Credit Parties
175 Technology Drive, Suite 175
Irvine, CA 92618
Leased business location operated by Credit Parties
Hashita 5 Caesarea
Caesarea Israel
Leased business location operated by Credit Parties
759-767 Springvale Road, Mulgrave, Victoria, 3170,
Australia
Schedule 9.2(d) – Chattel Paper, Letter of Credit Rights, Commercial Tort Claims, Instruments, Documents, Investment Property
None.